Gynecology

This case emphasizes the importance of keeping detailed records of each patient encounter.

How would a male gynecologist begin to know anything about a woman's orgasm? Easy. In my pre-operative counseling for hysterectomy I discuss sexuality, orgasm, and hysterectomy. And I tell my patient that a year later I'm going to ask her about it. But this is not a controlled scientific study, so before telling you what I am hearing, let's look at some real data.

Dr Greenberg reports on his results with an anti-stick solution for electrosurgery and a wireless endoscope camera.

For Contemporary OB/GYN, Dr Bobby Lazzara discusses the recent lawsuits that claim talc powder usage led to ovarian cancer and how it may affect your recommendations.

A commentary on ACOG Practice Bulletin Number 154: Operative Vaginal Delivery by Charles J Lockwood, MD, MHCM.

Do sex hormone level changes from ovary removal increase colorectal cancer risk? Plus: The CDC releases the newest information on the birth rate among teenagers. Also, a look at the impact of hyperglycemia and excessive weight gain on offspring.

Home birth can carry risks, regardless of whether the woman has previously delivered, and prior cesarean delivery can also carry risks. This session examined the risks that can occur among women who choose home birth with a history of at least one cesarean delivery.

A new study looks at whether breast density letters are too difficult for the typical woman to understand. Plus: The FDA issues a warning on fluconazole and miscarriage. Also, do irregular menses provide protection against ovarian cancer or increase risk?

Contemporary OB/GYN readers speak up about exploratory laparotomy, the cesarean epidemic, and the difficulty to re-enter ob.

A new study looks at whether ovary-sparing hysterectomies can lead to early menopause. Plus: Does betamethasone reduce respiratory complications in preterm infants? Also, the impact of the vaginal microbiome on preterm birth.

Ob/gyns' fear of being sued may be disproportionate to the frequency of malpractice claims.

The FDA approves the first containment system for morcellation. Plus: ASRM provides guidance for Zika virus. And, the impact of HRT timing and its impact on cardiovascular disease.

The CDC offers new guidance on Zika virus and the labor and delivery unit. Plus: How are out-of-hospital trends moving? Also, a look at whether or not planned cesareans mean poorer outcomes for children.

Patients with GD are increasingly likely to present for care, and ob/gyns should be familiar with the latest management guidelines.

Evidence on which to base management of RPL is limited, challenging ob/gyns with patients facing this stressful diagnosis.

When a jury sees a diagnosis of HIE, it is very difficult to show them that no hypoxia occurred in labor, even in the face of normal cord blood gases.

An update on the Zika virus and its impact on your practice. And, a look at whether or not vaginal delivery increases risk of incontinence. Plus: What was the impact of the HPV vaccine on HPV rates?

Can Zika be considered a sexually transmitted infection?

Surgeons at the Cleveland Clinic performed the procedure in hopes of "curing" absolute uterine-factor infertility, but announced on March 9 that the organ had had to be removed.

A look at the impact of prehypertension on the risk of stillbirth. And, the CDC issues guidance on alcohol consumption in women of childbearing years. Plus: Does the type of hysterectomy alter endometrial cancer survival?

Women with BRCA gene mutations face tough decisions but they have options.

It may difficult to arrive at a diagnosis in cases of acute pain.

A self-sampling device being used in Canada is receiving high marks from patients.

Geographic factors predict likelihood of HPV vaccine initiation rates, a study finds.

A January 4th action by the US Food and Drug Administration (FDA) reclassified transvaginal mesh implants for pelvic organ prolapse (POP) as class III (or high-risk) medical devices requiring premarket approval application (PMA).

The study was designed for tight control of the usual variables.

If proven effective, the vaccine, called VGX-3100, would be the first non-ablative therapy for cervical precancer.

Surgical mesh for pelvic organ prolapse (POP) is a class III or high-risk medical device requiring premarket approval application (PMA) following new action by the Food and Drug Administration (FDA).

Did it occur during surgery, or did a later injury lead to it?